F047 Autoimmune Blistering Diseases: What's New?
DESCRIPTION
This session will focus on new advances in AIBD regarding the current treatments and new treatments in trials for pemphigus, pemphigoids, LABD and EBA, along with how the FDA examines this evidence.
LEARNING OBJECTIVES
Discuss the evidence behind current and new treatments for pemphigus and how the FDA evaluates the evidence
Discuss the evidence behind current treatments and treatments in trials for bullous pemphigoid and how they might fit into clinical practice
Discuss the current and potential new treatments in trials for LABD, MMP and EBA
SCHEDULE
3:30 PM
Introduction
Dedee F. Murrell, MD, FAAD
3:32 PM
What’s New in Pemphigus Management
Aikaterini Patsatsi, MD, PhD, IFAAD
4:08 PM
Questions re pemphigus and FDA
Aikaterini Patsatsi, MD, PhD, IFAAD, Victoria P. Werth, MD, FAAD
4:15 PM
What’s new in clinical trials in Bullous Pemphigoid
Dedee F. Murrell, MD, FAAD
4:33 PM
How to apply the new data to clinical management of BP-
Pascal Joly, MD, PhD, IFAAD
4:52 PM
Questions re Bullous Pemphigoid treatment
Dedee F. Murrell, MD, FAAD, Pascal Joly, MD, PhD, IFAAD
5:00 PM
Emerging Drugs in Rare Forms of Pemphigoids (LABD, MMP, EBA)
Frederic Caux, PhD
5:20 PM
Questions re LABD, MMP & EBA treatments
Frederic Caux, PhD
5:25 PM
Closing remarks
Dedee F. Murrell, MD, FAAD
DIRECTOR
Dedee F. Murrell, MD, FAAD
SPEAKERS
Frederic Caux, PhD
Pascal Joly, MD, PhD, IFAAD
Aikaterini Patsatsi, MD, PhD, IFAAD
Victoria P. Werth, MD, FAAD
DISCLOSURES
Frederic Caux, PhD
arGEN-X – Investigator(Fees); Boehringer Ingelheim – Advisory Board(Honoraria); Eli Lilly – Speaker(Honoraria); Galderma – Advisory Board(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Speaker(Honoraria); Regeneron – Investigator(Fees); Sanofi – Advisory Board(Honoraria), Speaker(Honoraria);
Pascal Joly, MD, PhD, IFAAD
AbbVie – Consultant (1099 relationship)(Fees); arGEN-X – Consultant(Honoraria); AstraZeneca – Consultant(Honoraria); BMS – Advisory Board(Honoraria); Glycoera – Consultant (1099 relationship)(Honoraria); janssen – Advisory Board(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Novartis Pharmaceuticals Corp. – Consultant(Honoraria); sanofi-aventis – Consultant(Honoraria); TOPAZ Pharmaceuticals, Inc. – Consultant(Honoraria); UCB – Advisory Board(Honoraria);
Dedee F. Murrell, MD, FAAD
Abbott Laboratories – Advisory Board(Honoraria), Speaker(Honoraria); AbbVie – Investigator(Grants/Research Funding); Actavis – Speaker/Faculty Education(Honoraria); Almirall – Consultant(Honoraria); Amgen – Investigator(Fees); Amicus Therapeutics – Advisory Board(Honoraria); Amryt Pharma – Investigator(Fees); Anacor Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Arena Pharmaceuticals – Investigator(Grants/Research Funding); arGEN-X – Investigator(Fees); Ascent Pharmaceuticals – Speaker(Honoraria); Castle Creek Pharmaceuticals – Consultant(Fees); Chiesi Farmaceutici – Advisory Board(Fees); CSL – Speaker(Grants/Research Funding), Speaker(Honoraria); Delfin Technology – Investigator(Equipment); Eli Lilly and Company – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding), Investigator(Other Financial Benefit); Janssen-Ortho Inc. – Other(Grants/Research Funding); Leo Pharma Inc – Speaker/Faculty Education(Honoraria); Medimmune – Investigator(Grants/Research Funding); Merck Serono – Investigator(Fees), Investigator(Grants/Research Funding); Molynlycke – Speaker(Grants/Research Funding); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Pierre Fabre Dermo-Cosmétique US – Speaker(Honoraria); Principia Biopharma Inc – Consultant(Honoraria); Roche Laboratories – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Samumed, LLC – Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees), Investigator(Fees), Investigator(Grants/Research Funding); Schering-Plough Corporation – Investigator(Grants/Research Funding), Speaker(Other Financial Benefit); Shire – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Stiefel a GSK company – Speaker(Honoraria); XOMA (US) LLC – Investigator(Grants/Research Funding);
Aikaterini Patsatsi, MD, PhD, IFAAD
AbbVie – Speaker(Honoraria); Argenx – Advisory Board(Honoraria); Innovaderm Research Inc. – Advisory Board(Honoraria); Johnson and Johnson – Speaker(Honoraria); Leo Pharma Inc – Speaker(Honoraria); Novartis Hellas – Speaker(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Pharmaserv Lilly – Speaker(Honoraria); Sanofi – Speaker(Honoraria); UCB – Speaker(Honoraria);
Victoria P. Werth, MD, FAAD
AbbVie – Consultant (1099 relationship)(Fees); Amgen – Investigator(Grants/Research Funding); AnaptysBio – Consultant(Honoraria); Architect Therapeutics – Consultant (1099 relationship)(Fees); argenx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Astra Zeneca – Investigator(Grants/Research Funding); AstraZeneca – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria), Data Safety Monitoring Board(Honoraria); Atticus Pharma, Inc. – Consultant (1099 relationship)(Honoraria); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); BMS – Consultant(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Honoraria); Cabaletta Bio – Consultant (1099 relationship)(Honoraria); Celexor Bio – Consultant (1099 relationship)(Fees); Corbus Pharmaceuticals – Investigator(Grants/Research Funding); CSL Behring – Consultant(Honoraria), Investigator(Grants/Research Funding); Cugene – Consultant(Honoraria); Duality Bio – Consultant (1099 relationship)(Fees); EMD Serono – Consultant(Honoraria); Everest Clinical Research – Consultant (1099 relationship)(Honoraria); Exo Therapeutics – Consultant (1099 relationship)(Honoraria); Gilead Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); GlaxoSmithKline – Consultant(Honoraria); Glycoera – Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Immunovant – Consultant (1099 relationship)(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Grants/Research Funding); Kyowa Hakko Kirin Pharma, Inc. – Consultant(Honoraria); Lilly ICOS LLC – Consultant(Honoraria); Lumanity – Consultant (1099 relationship)(Honoraria); Lupus Foundation of America – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); Novartis – Advisory Board(Honoraria); Nuvig Therapeutics – Consultant (1099 relationship)(Honoraria); Odyssey Therapeutics – Consultant (1099 relationship)(Fees); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Priovant Therapeutics – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); ROME Therapeutics – Consultant(Honoraria); Sanofi Aventis – Consultant(Honoraria); UCB – Consultant(Honoraria); Ventus Therapeutics – Investigator(Grants/Research Funding); Viela Bio – Consultant(Honoraria), Investigator(Grants/Research Funding); Vindico Medical Education – Speaker/Faculty Education(Honoraria);